- Conditions
- Adenovirus Types B/C/E, Coxsackie Virus/Echovirus, Human Metapneumovirus A/B, Infection Due to Human Parainfluenza Virus 1, Influenza A, Parainfluenza Type 2, Parainfluenza Type 3, Parainfluenza Type 4, QIAGEN ResPlex II Advanced Panel, Respiratory Syncytial Virus Infections, Rhinovirus
- Interventions
- artus Influenza A/B RT-PCR Test
- Lead sponsor
- QIAGEN Gaithersburg, Inc
- Industry
- Eligibility
- Not listed
- Enrollment
- 272 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 5
- States / cities
- Tuscon, Arizona • Albany, New York • Chapel Hill, North Carolina + 1 more
Source: ClinicalTrials.gov public record
Updated May 9, 2017 · Synced May 18, 2026, 11:59 AM EDT